ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,909Medicare Part D Prescriptions Filled, Including Refills

Rank: 40 out of 487

$433K Total Retail Price of All Prescriptions

Rank: 62 out of 487

374 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 374 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 374 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 4,823 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
SIMVASTATIN 355 224 1 4
LEVOTHYROXINE SODIUM 334 166 2 1
HYDROCODONE-ACETAMINOPHEN 327 108 S3 3 3
BENAZEPRIL-HYDROCHLOROTHIAZIDE 319 259 10 4 133
AMLODIPINE BESYLATE 280 230 5 6
OMEPRAZOLE 263 140 6 2
METFORMIN HCL 216 142 7 8
METFORMIN HCL ER 157 107 8 31
SERTRALINE HCL 128 63 9 21
METOPROLOL SUCCINATE 125 78 10 15
GLIMEPIRIDE 121 117 11 35
BENAZEPRIL HCL 117 110 12 67
MELOXICAM 117 69 12 26
GABAPENTIN 116 49 14 13
ALLOPURINOL 116 104 14 29
TRAZODONE HCL 115 41 16 22
LISINOPRIL 106 43 17 5
ZOLPIDEM TARTRATE 102 54 18 14
DOXAZOSIN MESYLATE 92 78 19 63
TORSEMIDE 92 46 19 138
ETODOLAC 89 59 21 107
CRESTOR 88 66 22 42
HYDROCHLOROTHIAZIDE 86 41 23 9
TRAMADOL HCL 83 68 24 19
POTASSIUM CHLORIDE 82 40 25 10
CITALOPRAM HBR 79 28 26 12
METHADONE HCL 76 0 S2 27 65
VENLAFAXINE HCL ER 74 0 28 55
WARFARIN SODIUM 71 71 29 11
PANTOPRAZOLE SODIUM 70 58 30 62
OXYCODONE HCL-ACETAMINOPHEN 69 0 S2 31 142
NORTRIPTYLINE HCL 68 30 32 156
PAROXETINE HCL 65 39 33 51
RANITIDINE HCL 64 0 34 39
CARVEDILOL 63 53 35 32
TAMSULOSIN HCL 63 55 35 25
PRAVASTATIN SODIUM 62 50 37 20
FUROSEMIDE 59 37 38 7
PROPRANOLOL HCL 59 0 38 92
DOXYCYCLINE HYCLATE 59 38 38 127
METHYLPHENIDATE HCL 58 22 41 239
TIZANIDINE HCL 58 0 41 129
CHLORTHALIDONE 57 51 43 119
TRIAMTERENE-HCTZ 57 45 43 49
PREMARIN 56 0 R 45 89
PROMETHAZINE HCL 54 0 R 46 101
NADOLOL 53 52 47 250
PREDNISONE 53 38 47 37
FLUOXETINE HCL 53 25 47 28
MOEXIPRIL-HYDROCHLOROTHIAZIDE 52 40 50 253
BUPROPION XL 51 11 51 97
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 24, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.